SORT1 and Insulin resistance: To assess the efficacy of FGF-21, Metrnl, and sortilin as biomarkers for differentiating individuals with metabolic syndrome, insulin resistance, carbohydrate disorders, and dyslipidemia, receiver operating characteristic (ROC) curve analysis was performed.